Background Implants or implantable devices should integrate into the host tissue faster than fibrous capsule formation, in which the design of the interface is one of the biggest challenges. Generally, bioactive materials are not viable for load-bearing applications, so inert biomaterials are proposed. However, the surface must be modified through techniques such as coating with bioactive materials, roughness and sized pores. The aim of this research was to validate an approach for the evaluation of the tissue growth on implants of porous alumina coated with bioactive materials. Methods Porous alumina implants were coated with 45S5 Bioglass® (BG) and hydroxyapatite (HA) and implanted in rat tibiae for a period of 28 days. Ex vivo resections were performed to analyze osseointegration, along with histological analysis, Scanning Electron Microscopy with Energy Dispersive X-Ray spectroscopy (SEM-EDX) line scanning, radiography and biomechanical testing. Results Given that the process of implant integration needs with the bone tissue to be accelerated, it was then seen that BG acted to start the rapid integration, and HA acted to sustaining the process. Conclusions Inert materials coated with bioglass and HA present a potential for application as bone substitutes, preferably with pores of diameters between 100 μm and 400 μm and, restrict for smaller than 100 μm, because it prevents pores without organized tissue formation or vacant. Designed as functional gradient material, stand out for applications in bone tissue under load, where, being the porous surface responsible for the osseointegration and the inner material to bear and to transmit the loads.
This study aimed to evaluate the osteointegration and genotoxic potential of a bioactive scaffold, composed of alumina and coated with hydroxyapatite and bioglass, after their implantation in tibias of rats. For this purpose, Wistar rats underwent surgery to induce a tibial bone defect, which was filled with the bioactive scaffolds. Histology analysis (descriptive and morphometry) of the bone tissue and the single-cell gel assay (comet) in multiple organs (blood, liver, and kidney) were used to reach this aim after a period of 30, 60, 90, and 180 days of material implantation. The main findings showed that the incorporation of hydroxyapatite and bioglass in the alumina scaffolds produced a suitable environment for bone ingrowth in the tibial defects and did not demonstrate any genotoxicity in the organs evaluated in all experimental periods. These results clearly indicate that the bioactive scaffolds used in this study present osteogenic potential and still exhibit local and systemic biocompatibility. These findings are promising once they convey important information about the behavior of this novel biomaterial in biological system and highlight its possible clinical application.
The objective of this study was to manufacture porous scaffolds with bioinert and bioactive materials to join mechanical properties and bony integration. Porous alumina ceramic matrices were produced using the slurry technique followed by isostatic pressing, leaching and sintering. Porous alumina samples presented 75.0vol% porosity and 52.27MPa of compressive strength. Bioglass/hydroxyapatite ceramic slurry was used as coating on alumina matrices. The infiltration was performed by dipping the alumina porous samples into bio-glass/hydroxyapatite ceramics slurry under vacuum and followed by sintering. The evaluation of the alumina ceramic scaffolds samples were made using EDX, mechanical and in vitro tests. For the in vitro tests, fibroblastic VERO cell line was employed. The porous alumina ceramic coated acquired a higher strength and more pronounced cell interaction than the non coated alumina scaffolds.
Introduction: The mechanical properties and corrosion resistance of a material are dependent on its microstructure and can be modifi ed by phase transformation. When a phase transformation occurs in a material it usually forms at least one new phase, with physical-chemical characteristics that differ from the original phase. Moreover, most phase transformations do not occur instantly. This paper presents an evaluation of the phase transformation of martensitic stainless steels ASTM 420A and ASTM 440C when submitted to different thermal processes. Methods: Dilatometry tests were performed with several continuous heating and cooling rates in order to obtain the profi les of the continuous heating transformation (CHT) and continuous cooling transformation (CCT) diagrams for these two types of steel. Also, the temperature ranges for the formation of the different phases (ferrite and carbides; ferrite; austenite and carbides; non-homogeneous and homogeneous austenite phases) were identifi ed. Rockwell hardness (HRC) tests were performed on all thermally treated steels. Anodic and cathodic potential dynamic polarization measurements were carried out through immersion in enzymatic detergent as an electrolyte for different samples submitted to the thermal processes in order to select the best routes for the heat treatment and to recommend steels for the manufacture of surgical tools. Results: The martensitic transformation temperature tends to increase with increasing temperature for the initiation of cooling. The 440C steel had a higher hardness value than the 420A steel at the austenitizing temperature of 1100 °C. Above the austenitizing temperature of 1100 °C, the material does not form martensite at the cooling rate used, which explains the sharp decline in the hardness values. Conclusion: The study reported herein achieved its proposed objectives, successfully investigating the issues and indicating solutions to the industrial problems addressed, which are frequently encountered in the manufacture of surgical instruments.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.